This broad distribution underpins its capacity to modulate both neuronal excitability and immune activation, positioning KOR as a compelling therapeutic target in disorders that bridge neurological and immunological dysfunction—such as atopic dermatitis (AD), multiple sclerosis (MS), and other neuro-inflammatory conditions. This evidence concerns the gene OPRK1 and atopic eczema.